Interpace Diagnostics Group, Inc.·4

Mar 9, 5:30 PM ET

Early James 4

4 · Interpace Diagnostics Group, Inc. · Filed Mar 9, 2018

Insider Transaction Report

Form 4
Period: 2018-03-07
Early James
Chief Financial Officer
Transactions
  • Award

    Stock Option(right to buy)

    2018-03-07+56,00056,000 total
    Exercise: $1.01Exp: 2028-03-07Common Stock (56,000 underlying)
  • Award

    Common Stock

    2018-03-07+14,00014,000 total
Footnotes (3)
  • [F1]The restricted units vest annually, in equal installments, over a three-year period, commencing on March 7, 2019.
  • [F2]Each restricted unit represents the contingent right to receive one share of common stock of Interpace Diagnostics Group, Inc. (the "Issuer").
  • [F3]The option award vests and becomes exercisable over a three-year period, in equal installments, commencing on March 7, 2019, subject to the reporting person's continued service with the Issuer.

Documents

1 file
  • 4
    form4.xmlPrimary